Skip to main content

Table 1 Baseline characteristics of participants with/without hysterectomy from the Korea National Health Insurance Database, 2007-2020a

From: The increased risk of colorectal cancer in the women who underwent hysterectomy from the South Korean National Health Insurance Database

 

Non-Hysterectomy, %

Hysterectomy, %

Total, %

p-value†

Number of participants

89,768

66,204

155,972

 

Adnexal surgery during hysterectomy

 Hysterectomy

 

77.7

77.7

 

 Hysterectomy + adnexal surgery

 

22.3

22.3

 

Median age (years)

48 [43–53]

46 [44–49]

47 [44–52]

 < 0.001

Age at inclusion (years)

   

 < 0.001

 40 ~ 44

30.9

32.7

31.6

 

 45 ~ 49

24.2

43.7

32.5

 

 50 ~ 54

25.1

20.1

23.0

 

 55 ~ 59

19.8

3.6

12.9

 

Year at inclusion

   

 < 0.001

 2011

21.3

29.1

24.6

 

 2012

22.6

25.8

24.0

 

 2013

27.3

23.2

25.5

 

 2014

28.9

21.9

25.9

 

SES

   

 < 0.001

 Mid ~ high SES

96.8

97.7

97.2

 

 Low SES

3.2

2.3

2.8

 

Region

   

 < 0.001

 Urban area

53.4

64.0

57.9

 

 Rural area

46.6

36.0

42.1

 

CCI

   

 < 0.001

 0

74.3

76.9

75.4

 

 1

14.6

13.2

14

 

  ≥ 2

11.1

9.9

10.6

 

Parity in cohort

   

 < 0.001

 0

96

98.7

97.1

 

 1

2.5

0.9

1.9

 

  ≥ 2

1.5

0.4

1.0

 

Menopause before inclusion

   

 < 0.001

 Absent

79.4

91.8

84.6

 

 Present

20.6

8.2

15.4

 

MHT before inclusion

   

 < 0.001

 Absent

96.1

98.6

97.1

 

 Present

3.9

1.4

2.9

 

Adnexal surgery before inclusion

   

 < 0.001

 Absent

98.1

98.9

98.5

 

 Present

1.9

1.1

1.5

 

Diseases of the gallbladder and biliary tract before inclusion

   

 < 0.001

 Absent

98.3

98.7

98.5

 

 Present

1.7

1.3

1.5

 

Uterine leiomyoma

   

 < 0.001

 Absent

90.9

21.0

61.2

 

 Present

9.1

79.0

38.8

 

Endometriosis

   

 < 0.001

 Absent

97.9

73.3

87.5

 

 Present

2.1

26.7

12.5

 

MHT after inclusion

   

 < 0.001

 Absent

93.0

85.7

89.9

 

 Present

7.0

14.3

10.1

 
  1. CCI Charlson comorbidity index, MHT menopausal hormone therapy, SES socioeconomic status
  2. †p-value less than 0.05 is statistically significant
  3. aData are expressed as percentage without number